With transformative digital technologies playing an increasingly critical role in health care delivery, the two companies have joined forces on a digital genomic solution that will increase efficiencies and outcomes within the highly specialized space of oncology. NEW...
In an interview with Targeted Oncology, Hearn Jay Cho, MD, PhD, Chief Medical Officer of MMRF and Associate Professor of Hematology and Medical Oncology at Mount Sinai Hospital Ruttenberg Treatment Center and Irene M. Ghobrial, MD, Director of the Clinical...
GenomeWeb is hosting a virtual expert panel to discuss challenges, opportunities, and controversies related to informing clinicians, cancer patients, and their families of potential germline insights after receiving somatic testing. This case-based discussion will...
Paired tumor/germline testing is far from standard practice in cancer care, but some experts in the field are advocating that when patients have their tumors genomically profiled to determine precision medicine options, that is an opportunity to also evaluate them for...
It’s been five years since Angelina Jolie announced to the world she carries a BRCA1 mutation and had a prophylactic double mastectomy to lower her risks of developing breast cancer. Below genetic counselors reflect on the impact she has made by sharing her...
